Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 8

Results: 19

Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1753, doi. 10.1111/bph.15754

By:

Riemma, Maria A.;
Cerqua, Ida;
Romano, Barbara;
Irollo, Elena;
Bertolino, Antonio;
Camerlingo, Rosa;
Granato, Elisabetta;
Rea, Giuseppina;
Scala, Stefania;
Terlizzi, Michela;
Spaziano, Giuseppe;
Sorrentino, Rosalinda;
D'Agostino, Bruno;
Roviezzo, Fiorentina;
Cirino, Giuseppe

Publication type:

Article

Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders.

Published in:

2022

By:

Bailey, Alexis;
Berwick, Daniel C.;
Camarini, Rosana;
Scavone, Cristoforo

Publication type:

Editorial

Metabolic phenotyping of opioid and psychostimulant addiction: A novel approach for biomarker discovery and biochemical understanding of the disorder.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1578, doi. 10.1111/bph.15475

By:

Caspani, Giorgia;
Sebők, Viktoria;
Sultana, Nowshin;
Swann, Jonathan R.;
Bailey, Alexis

Publication type:

Article

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1525, doi. 10.1111/bph.15451

By:

Martins, Daniel;
Paduraru, Maria;
Paloyelis, Yannis

Publication type:

Article

Can rodent models elucidate the pathomechanisms of genetic epilepsy?

Published in:

2022

By:

Okada, Motohiro

Publication type:

journal article

A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1769, doi. 10.1111/bph.15750

By:

Abd‐Elrahman, Khaled S.;
Sarasija, Shaarika;
Colson, Tash‐Lynn L.;
Ferguson, Stephen S. G.

Publication type:

Article

A novel peptide inhibitor of Dll4‐Notch1 signalling and its pro‐angiogenic functions.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1716, doi. 10.1111/bph.15743

By:

Zhu, Guofu;
Lin, Ying;
Ge, Tandi;
Singh, Shekhar;
Liu, Hao;
Fan, Linlin;
Wang, Shumin;
Rhen, Jordan;
Jiang, Dongyang;
Lyu, Yuyan;
Yin, Yiheng;
Li, Xiankai;
Benoit, Danielle S. W.;
Li, Weiming;
Xu, Yawei;
Pang, Jinjiang

Publication type:

Article

Endothelial AMPKα1/PRKAA1 exacerbates inflammation in HFD‐fed mice.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1661, doi. 10.1111/bph.15742

By:

Yang, Qiuhua;
Ma, Qian;
Xu, Jiean;
Liu, Zhiping;
Mao, Xiaoxiao;
Zhou, Yaqi;
Cai, Yongfeng;
Da, Qingen;
Hong, Mei;
Weintraub, Neal L.;
Fulton, David J.;
Belin de Chantemèle, Eric J.;
Huo, Yuqing

Publication type:

Article

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1G93A mice.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1732, doi. 10.1111/bph.15738

By:

Scaricamazza, Silvia;
Salvatori, Illari;
Amadio, Susanna;
Nesci, Valentina;
Torcinaro, Alessio;
Giacovazzo, Giacomo;
Primiano, Aniello;
Gloriani, Michela;
Candelise, Niccolò;
Pieroni, Luisa;
Loeffler, Jean‐Philippe;
Renè, Frederique;
Quessada, Cyril;
Tefera, Tesfaye W.;
Wang, Hao;
Steyn, Frederik J.;
Ngo, Shyuan T.;
Dobrowolny, Gabriella;
Lepore, Elisa;
Urbani, Andrea

Publication type:

Article

N‐Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1679, doi. 10.1111/bph.15737

By:

Romano, Barbara;
Pagano, Ester;
Iannotti, Fabio A.;
Piscitelli, Fabiana;
Brancaleone, Vincenzo;
Lucariello, Giuseppe;
Nanì, Maria Francesca;
Fiorino, Ferdinando;
Sparaco, Rosa;
Vanacore, Giovanna;
Di Tella, Federica;
Cicia, Donatella;
Lionetti, Ruggero;
Makriyannis, Alexandros;
Malamas, Michael;
De Luca, Marcello;
Aprea, Giovanni;
D'Armiento, Maria;
Capasso, Raffaele;
Sbarro, Bernardo

Publication type:

Article

Activation of D1/D5 receptors ameliorates decreased intrinsic excitability of hippocampal neurons induced by neonatal blockade of N‐methyl‐d‐aspartate receptors.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1695, doi. 10.1111/bph.15735

By:

Griego, Ernesto;
Hernández‐Frausto, Melissa;
Márquez, Luis A.;
Lara‐Valderrabano, Leonardo;
López Rubalcava, Carolina;
Galván, Emilio J.

Publication type:

Article

Diazepam attenuates the effects of cocaine on locomotion, 50‐kHz ultrasonic vocalizations and phasic dopamine in the nucleus accumbens of rats.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1565, doi. 10.1111/bph.15658

By:

Sanchez, William N.;
Pochapski, Jose A.;
Jessen, Leticia F.;
Ellenberger, Marek;
Schwarting, Rainer K.;
Robinson, Donita L.;
Andreatini, Roberto;
Da Cunha, Claudio

Publication type:

Article

How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1640, doi. 10.1111/bph.15584

By:

Kimura, Louise F.;
Novaes, Leonardo S.;
Picolo, Gisele;
Munhoz, Carolina D.;
Cheung, Chi W.;
Camarini, Rosana

Publication type:

Article

Group II metabotropic glutamate receptor (mGlu2 and mGlu3) roles in thalamic processing.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1607, doi. 10.1111/bph.15640

By:

Copeland, Caroline S.;
Neale, Stuart A.;
Nisenbaum, Eric S.;
Salt, Thomas E.

Publication type:

Article

The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1478, doi. 10.1111/bph.15575

By:

Azeggagh, Sonia;
Berwick, Daniel C.

Publication type:

Article

Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1496, doi. 10.1111/bph.15570

By:

Leite, Jefferson A.;
Ghirotto, Bruno;
Targhetta, Vitor P.;
de Lima, Jean;
Câmara, Niels O. S.

Publication type:

Article

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1544, doi. 10.1111/bph.15481

By:

Rae, Mariana;
Lemos Duarte, Mariana;
Gomes, Ivone;
Camarini, Rosana;
Devi, Lakshmi A.

Publication type:

Article

Issue Information.

Published in:: British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1473, doi. 10.1111/bph.15551
Publication type:: Article

The Janus face of ouabain in Na+/K+‐ATPase and calcium signalling in neurons.

Published in:

British Journal of Pharmacology, 2022, v. 179, n. 8, p. 1512, doi. 10.1111/bph.15419

By:

Kinoshita, Paula Fernanda;
Orellana, Ana Maria Marques;
Nakao, Vinicius Watanabe;
de Souza Port's, Natacha Medeiros;
Quintas, Luis Eduardo Menezes;
Kawamoto, Elisa Mitiko;
Scavone, Cristoforo

Publication type:

Article

Works matching IS 00071188 AND DT 2022 AND VI 179 AND IP 8

Sphingosine‐1‐phosphate/TGF‐β axis drives epithelial mesenchymal transition in asthma‐like disease.

Building Bridges In Neuropharmacology: New therapeutic approaches for psychiatric and neurodegenerative disorders.

Metabolic phenotyping of opioid and psychostimulant addiction: A novel approach for biomarker discovery and biochemical understanding of the disorder.

Heterogeneity in response to repeated intranasal oxytocin in schizophrenia and autism spectrum disorders: A meta‐analysis of variance.

Can rodent models elucidate the pathomechanisms of genetic epilepsy?

A positive allosteric modulator for the muscarinic receptor (M1 mAChR) improves pathology and cognitive deficits in female APPswe/PSEN1ΔE9 mice.

A novel peptide inhibitor of Dll4‐Notch1 signalling and its pro‐angiogenic functions.

Endothelial AMPKα1/PRKAA1 exacerbates inflammation in HFD‐fed mice.

Repurposing of Trimetazidine for amyotrophic lateral sclerosis: A study in SOD1<sup>G93A</sup> mice.

N‐Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth.

Activation of D1/D5 receptors ameliorates decreased intrinsic excitability of hippocampal neurons induced by neonatal blockade of N‐methyl‐d‐aspartate receptors.

Diazepam attenuates the effects of cocaine on locomotion, 50‐kHz ultrasonic vocalizations and phasic dopamine in the nucleus accumbens of rats.

How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.

Group II metabotropic glutamate receptor (mGlu<sub>2</sub> and mGlu<sub>3</sub>) roles in thalamic processing.

The development of inhibitors of leucine‐rich repeat kinase 2 (LRRK2) as a therapeutic strategy for Parkinson's disease: the current state of play.

Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders.

Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects.

Issue Information.

The Janus face of ouabain in Na<sup>+</sup>/K<sup>+</sup>‐ATPase and calcium signalling in neurons.